Log In
Print
BCIQ
Print
Print this Print this
 

RTI-79

  Manage Alerts
Collapse Summary General Information
Company Rescue Therapeutics Inc.
DescriptionAnsamycin-class compound designed to enhance the efficacy of secondline therapy DOXIL (doxorubicin) in drug-resistant cancer cells
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today